Journal of Vaccine Research 2024, Vol.14, No.2, 65-75 http://medscipublisher.com/index.php/jvr 75 Zhang H., and Xia X., 2021, RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy, Human Vaccines and Immunotherapeutics, 17(9): 2995-2998. https://doi.org/10.1080/21645515.2021.1921524 PMid:33945399 PMCid:PMC8381784 Zhang L., Zhao J., Hu X., Wang C., Jia Y., Zhu C., Xie S., Lee J., Li F., and Ling D., 2022, A peritumorally injected immunomodulating adjuvant elicits robust and safe metalloimmunotherapy against solid tumors, Advanced Materials, 34(41): 2206915. https://doi.org/10.1002/adma.202206915 PMid:35986645 Zhao Y., Wei K., Chi H., Xia Z., and Li X., 2022, IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?, Frontiers in Immunology, 13: 1022808. https://doi.org/10.3389/fimmu.2022.1022808 PMid:36389666 PMCid:PMC9650235
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==